1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Willbold, D. Hoffmann, S. Rosch, P. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking IX Eur.J.Biochem. EJBCAI 0262 0014-2956 245 581 588 10.1111/j.1432-1033.1997.t01-1-00581.x 9182993 Secondary structure and tertiary fold of the human immunodeficiency virus protein U (Vpu) cytoplasmic domain in solution. 1997 10.2210/pdb1vpu/pdb pdb_00001vpu 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 5111.440 VPU PROTEIN CYTOPLASMIC DOMAIN RESIDUES 39 - 81 R37L, K38Q 1 man polymer VPU(39-81) no no LQIDRLIDRITERAEDSGNESEGDQEELSALVERGHLAPWDVDDL LQIDRLIDRITERAEDSGNESEGDQEELSALVERGHLAPWDVDDL A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Lentivirus SF162 ISOLATE Escherichia Escherichia coli sample BL21 SYNTHETIC GENE 11676 Human immunodeficiency virus 1 469008 Escherichia coli BL21(DE3) BL21 (DE3) PET16B (NOVAGEN) PLASMID PET16B (NOVAGEN) database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1997-05-15 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-03-02 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site Y BNL 1997-01-28 REL REL REPRESENTATIVE MODEL NUMBER: 3 ENERGY, AGREEMENT WITH EXPERIMENTAL DATA 25 9 NOESY (100 150 200 MS MIXING TIME) 7.0 298 K SIMULATED ANNEALING, RESTRAINED MOLECULAR DYNAMICS structure solution NDEE structure solution X-PLOR refinement X-PLOR 600 Bruker AMX600 LEU 37 n 1 LEU 37 A GLN 38 n 2 GLN 38 A ILE 39 n 3 ILE 39 A ASP 40 n 4 ASP 40 A ARG 41 n 5 ARG 41 A LEU 42 n 6 LEU 42 A ILE 43 n 7 ILE 43 A ASP 44 n 8 ASP 44 A ARG 45 n 9 ARG 45 A ILE 46 n 10 ILE 46 A THR 47 n 11 THR 47 A GLU 48 n 12 GLU 48 A ARG 49 n 13 ARG 49 A ALA 50 n 14 ALA 50 A GLU 51 n 15 GLU 51 A ASP 52 n 16 ASP 52 A SER 53 n 17 SER 53 A GLY 54 n 18 GLY 54 A ASN 55 n 19 ASN 55 A GLU 56 n 20 GLU 56 A SER 57 n 21 SER 57 A GLU 58 n 22 GLU 58 A GLY 59 n 23 GLY 59 A ASP 60 n 24 ASP 60 A GLN 61 n 25 GLN 61 A GLU 62 n 26 GLU 62 A GLU 63 n 27 GLU 63 A LEU 64 n 28 LEU 64 A SER 65 n 29 SER 65 A ALA 66 n 30 ALA 66 A LEU 67 n 31 LEU 67 A VAL 68 n 32 VAL 68 A GLU 69 n 33 GLU 69 A ARG 70 n 34 ARG 70 A GLY 71 n 35 GLY 71 A HIS 72 n 36 HIS 72 A LEU 73 n 37 LEU 73 A ALA 74 n 38 ALA 74 A PRO 75 n 39 PRO 75 A TRP 76 n 40 TRP 76 A ASP 77 n 41 ASP 77 A VAL 78 n 42 VAL 78 A ASP 79 n 43 ASP 79 A ASP 80 n 44 ASP 80 A LEU 81 n 45 LEU 81 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 1 A ARG 41 0.317 SIDE CHAIN 1 A ARG 45 0.291 SIDE CHAIN 1 A ARG 49 0.283 SIDE CHAIN 1 A ARG 70 0.290 SIDE CHAIN 2 A ARG 41 0.306 SIDE CHAIN 2 A ARG 45 0.280 SIDE CHAIN 2 A ARG 49 0.315 SIDE CHAIN 2 A ARG 70 0.282 SIDE CHAIN 3 A ARG 41 0.304 SIDE CHAIN 3 A ARG 45 0.317 SIDE CHAIN 3 A ARG 49 0.296 SIDE CHAIN 3 A ARG 70 0.318 SIDE CHAIN 4 A ARG 45 0.303 SIDE CHAIN 4 A ARG 49 0.251 SIDE CHAIN 4 A ARG 70 0.297 SIDE CHAIN 5 A ARG 41 0.281 SIDE CHAIN 5 A ARG 45 0.269 SIDE CHAIN 5 A ARG 49 0.287 SIDE CHAIN 5 A ARG 70 0.303 SIDE CHAIN 6 A ARG 41 0.258 SIDE CHAIN 6 A ARG 45 0.310 SIDE CHAIN 6 A ARG 49 0.319 SIDE CHAIN 6 A ARG 70 0.303 SIDE CHAIN 7 A ARG 41 0.269 SIDE CHAIN 7 A ARG 45 0.199 SIDE CHAIN 7 A ARG 49 0.261 SIDE CHAIN 7 A ARG 70 0.292 SIDE CHAIN 8 A ARG 41 0.306 SIDE CHAIN 8 A ARG 45 0.310 SIDE CHAIN 8 A ARG 49 0.288 SIDE CHAIN 8 A ARG 70 0.290 SIDE CHAIN 9 A ARG 41 0.307 SIDE CHAIN 9 A ARG 45 0.289 SIDE CHAIN 9 A ARG 49 0.258 SIDE CHAIN 9 A ARG 70 0.215 SIDE CHAIN 1 A ILE 39 -64.25 -77.64 1 A GLU 51 56.64 6.65 1 A GLU 56 -69.49 98.13 1 A SER 57 78.10 -11.62 1 A GLU 58 37.06 -129.00 1 A LEU 64 -96.63 -85.58 1 A SER 65 59.91 160.81 1 A ALA 66 65.00 -64.32 1 A ARG 70 -46.00 104.76 1 A LEU 73 -51.01 105.96 1 A ALA 74 -172.08 -170.94 2 A ASP 40 74.97 -25.73 2 A GLU 51 61.79 -30.87 2 A SER 53 -93.07 33.67 2 A GLU 58 71.51 -62.68 2 A SER 65 60.00 -90.96 2 A GLU 69 -84.12 42.75 2 A HIS 72 177.48 -46.23 2 A LEU 73 20.56 90.71 2 A ALA 74 -176.38 -165.67 3 A GLU 51 54.18 14.59 3 A SER 57 -164.52 47.83 3 A LEU 67 -107.52 -60.14 3 A VAL 68 47.90 72.14 3 A ARG 70 -67.10 79.91 3 A HIS 72 41.51 94.32 3 A ALA 74 -170.56 -170.63 4 A GLN 38 -172.49 84.11 4 A ILE 39 -81.20 -109.90 4 A GLU 51 54.81 13.49 4 A GLU 58 50.98 -109.83 4 A GLU 69 -59.91 -9.14 4 A ARG 70 -43.88 108.59 4 A ALA 74 -171.77 -171.34 5 A GLN 38 -141.78 58.58 5 A GLU 51 57.32 -43.86 5 A SER 53 -98.99 39.10 5 A GLU 58 57.35 75.52 5 A LEU 64 -174.81 -42.04 5 A SER 65 -21.27 -44.98 5 A ALA 66 -16.02 -66.60 5 A LEU 67 -99.25 -79.87 5 A ALA 74 -160.55 -160.04 5 A PRO 75 -62.77 -93.70 5 A TRP 76 26.32 -80.64 6 A GLU 51 56.72 10.05 6 A SER 57 72.85 -62.89 6 A GLU 58 75.25 124.19 6 A SER 65 64.97 -58.42 6 A VAL 68 -91.56 58.85 6 A HIS 72 -151.74 -42.11 7 A GLN 38 61.88 63.40 7 A ILE 39 -122.16 -66.09 7 A SER 57 70.95 -65.12 7 A GLU 58 73.18 128.94 7 A SER 65 -26.87 -42.97 7 A LEU 67 -105.44 -60.48 7 A VAL 68 51.97 72.67 7 A HIS 72 28.23 58.66 7 A LEU 73 -66.65 -157.73 7 A ALA 74 65.91 -171.45 8 A ASP 40 73.35 -46.50 8 A GLU 51 53.76 19.96 8 A SER 57 68.41 -61.67 8 A GLU 58 76.41 115.13 8 A GLU 62 -143.66 -50.96 8 A LEU 64 -67.10 -71.82 8 A SER 65 53.71 -157.71 8 A ALA 66 65.12 -62.77 8 A ASP 80 74.41 -61.66 9 A ILE 39 -108.85 -111.62 9 A GLU 51 59.69 -42.35 9 A SER 57 -101.05 -61.69 9 A GLU 58 147.89 53.28 9 A LEU 64 -105.32 -60.66 9 A SER 65 68.42 -52.59 9 A ALA 66 -45.14 -72.31 9 A LEU 67 -66.44 -79.01 9 A VAL 68 30.50 61.97 9 A GLU 69 -69.35 33.02 9 A HIS 72 -155.52 -64.68 9 A LEU 73 162.15 -179.85 9 A ALA 74 53.16 -169.07 model building X-PLOR refinement X-PLOR phasing X-PLOR NMR SOLUTION STRUCTURE OF THE HIV-1 VPU CYTOPLASMIC DOMAIN, 9 STRUCTURES 1 Y N A ASP 40 A ASP 4 HELX_P A ALA 50 A ALA 14 1 1 11 A ASP 60 A ASP 24 HELX_P A GLU 63 A GLU 27 5 2 4 A PRO 75 A PRO 39 HELX_P A VAL 78 A VAL 42 1 3 4 AIDS HIV, VPU, AIDS VPU_HV1S1 UNP 1 1 P19554 MQPLQILAIVALVVAAIIAIVVWTIVYIEYRKILRQRKIDRLIDRITERAEDSGNESEGDQEELSALVERGHLAPWDVDD L 39 81 1VPU 39 81 P19554 A 1 3 45 1 P 1